STERIS (STE) reported fiscal Q4 adjusted net income late Monday of $2.83 per diluted share, up from $2.74 a year earlier.

Analysts polled by FactSet expected $2.85.

Revenue for the three months ended March 31 rose to $1.60 billion from $1.50 billion a year earlier.

Analysts surveyed by FactSet expected $1.60 billion.

STERIS expects full-year 2027 adjusted EPS guidance of $11.10 to $11.30.

Analysts expect $10.20.